Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
8/17/26 AstraZeneca (AZN) Orpathys for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
8/17/26 AstraZeneca (AZN) Tagrisso for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
8/13/26 ADC Therapeutics (ADCT) Zynlonta for Diffuse Large B-Cell Lymphoma (DLBCL) Subscribers Only Subscribers Only Subscribers Only
8/11/26 MoonLake (MLTX) sonelokimab for Psoriatic Arthritis (PsA) Subscribers Only Subscribers Only Subscribers Only
8/11/26 MoonLake (MLTX) sonelokimab for Psoriasis Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/17/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update